Showing all 4 results
Graft-Versus-Host Disease PBMC
Graft-versus-Host Disease PBMC samples are isolated from donors with clinically diagnosed graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation. Ideal for studying T cell–mediated immune responses, allo-reactivity, and mechanisms of tissue injury in acute and chronic GvHD.
Graft-Versus-Host Disease Plasma
Graft-versus-Host Disease Plasma samples are collected from donors experiencing graft-versus-host disease (GVHD). Suitable for analyzing cytokines, chemokines, and soluble biomarkers such as ST2 and Reg3α that are associated with disease severity, organ involvement, and therapeutic response.
Graft-Versus-Host Disease Serum
Graft-versus-Host Disease Serum samples are derived from donors with confirmed graft-versus-host disease (GVHD). Useful for evaluating immune dysregulation, inflammatory mediators, and potential predictive markers of treatment outcomes and relapse risk.
Graft-Versus-Host Disease Whole Blood
Graft-versus-Host Disease Whole Blood samples are obtained from donors with clinically diagnosed graft-versus-host disease (GVHD). Valuable for gene expression studies, immune cell profiling, and identifying molecular pathways involved in transplant-related complications.